-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-03-31
BLCO:NYE- (USD)
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 14.5Change
+0.37 (+2.62)%Market Cap
USD 5.64BVolume
1.90MVerdict
Verdict
Values as of: 2025-03-31
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 14.5Change
+0.37 (+2.62)%Market Cap
USD 5.64BVolume
1.90MVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
BDX | Becton Dickinson and Company |
N/A |
USD 65.91B |
ALC | Alcon AG |
N/A |
USD 46.01B |
RMD | ResMed Inc |
N/A |
USD 34.14B |
BAX | Baxter International Inc |
N/A |
USD 18.71B |
AVTR | Avantor Inc |
N/A |
USD 11.92B |
ATR | AptarGroup Inc |
N/A |
USD 10.16B |
TFX | Teleflex Incorporated |
N/A |
USD 6.39B |
STVN | Stevanato Group SpA |
N/A |
USD 5.88B |
WRBY | Warby Parker Inc |
N/A |
USD 2.55B |
INFU | InfuSystems Holdings Inc |
N/A |
USD 0.13B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
FSYD | Fidelity Sustainable High.. | 0.00 % | 0.00 % |
N/A |
USD 0.05B |
Market Performance vs. Industry/Classification (Medical Instruments & Supplies) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -19.71% | 37% | F | 10% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -19.71% | 37% | F | 10% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -15.01% | 58% | F | 19% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -15.01% | 58% | F | 17% | F | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 2.50% | 62% | D | 44% | F | ||
Dividend Return | 2.50% | 62% | D | 35% | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 13.69% | 95% | A | 69% | C- | ||
Risk Adjusted Return | 18.25% | 71% | C- | 34% | F | ||
Market Capitalization | 5.64B | 40% | F | 79% | B- |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector